"This is a public health crisis for children. And it demands action," Long Covid Families said in its promotion of the ...

BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...

Scientists have uncovered biological changes in gut bacteria, immune responses and metabolism that are potential flags for ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.

Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...

A new study from Northwestern University found that life expectancy in California has not returned to pre-pandemic levels, ...

Infants, toddlers and preschoolers exhibit symptoms of long COVID, but the symptoms can be different and more difficult to ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

The strain that H.R. 1 will put on Washington’s health care system will affect access for the entire region. There is no ...

A new study in cats with a fatal coronavirus infection suggests stem cell therapy could help tackle the immune damage behind ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Our fair value estimate is $20.50 per share. Our long-term sales assumption relies on continued innovation from the firm—which allocates 4% of sales to research and development—as well as long-term ...